Cancer Types
CANCER TYPES
Breast Cancer
Polypharmacy Increases Risk of Post Chemotherapy Inpatient Hospitalization for Older Patients
Patients with cancer aged 65 and older are likely to be taking 5 or more medications before treatment with IV chemotherapy, which can complicate posttreatment care.
Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
[Breast Cancer: Targets and Therapy] A retrospective chart review of a cohort of patients with TNBC found that tumor size and nodal status is associated with DFS, and radiotherapy technique and fractionation protocol were not associated with differences in either DFS or OS.
Cervical Cancer
Copper Intrauterine Devices Tied to Lower Risk for Cervical Cancer
Findings based on comparison to hormonal intrauterine devices.
Modeling Studies Show Cervical Cancer Could Be Eliminated
And mortality could be reduced by about one-third by 2030 and almost completely by 2120.
Colorectal Cancer
Adding Cetuximab to Chemotherapy Shortens Survival by 2 Years in Advanced CRC
Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.
Recurrence-Free and Overall Survival Better in Adult Patients With Colon Cancer
Patients older than 25 years have significantly higher rates of OS and RFS at 3 and 5 years compared with patients younger than 25.
Gastrointestinal Cancer
Following Helicobacter pylori Infection, Gastric Cancer Risk High
Avelumab Maintenance: No OS Benefit vs Continued Chemotherapy in HER2-Negative Gastrointestinal Cancers
Genitourinary Cancer
Long-Term AEs Persist in Some Survivors of Testicular Cancer
Mitomycin C May Reduce Urothelial Recurrence Risk in UTUC
Gynecologic Cancer
Fertility Treatment and Childhood Cancer Risk: What’s the Link?
Fertility-Sparing Surgery Achieves Good Oncologic, Obstetric Outcomes in Younger Women With Early-Stage Nonepithelial Ovarian Cancer
Leukemia
Newly Developed Rapid Point of Care Assay for Acute Promyelocytic Leukemia Diagnosis
Outpatient Induction Chemotherapy for Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Liver Cancer
Low-Dose Aspirin Reduced Risk of HCC in Patients With HBV or HCV
Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
Lung Cancer
Osimertinib-Associated Cardiac Toxicity: A Retrospective Study
Carboplatin Plus Pemetrexed Found Noninferior to Docetaxel in Older Patients With Nonsquamous NSCLC
Lymphoma
Induction in Transplant-Eligible Mantle Cell Lymphoma With Rituximab and Cytarabine Added to Rituximab and Bendamustine
Brentuximab Vedotin With Bendamustine for Patients With Refractory or Multiple Relapsed Classic Hodgkin Lymphoma
Melanoma
Minority of Melanomas With Complete Response to Anti–PD-1 Relapsed After Drug Cessation
Large Decrease Seen in Melanoma Mortality From 2013 to 2016
Multiple Myeloma
Glyphosate Exposure and Relative Risks of Non-Hodgkin Lymphoma or Multiple Myeloma
FDA Approves New Treatment Option for Multiple Myeloma
Ovarian Cancer
New Research Says There’s No Significant Link Between Talc and Ovarian Cancer, but Some Scientists Push Back Against the Study’s Data and Design
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer
Pancreatic Cancer
Treatment Options for Pancreatic Neuroendocrine Tumors
Molecularly Matched Therapy Promising in Pancreatic Cancer
Prostate Cancer
Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer
Surgical Approach Not Tied to Decision Regret After Prostatectomy
Want to read more?
Please login or register first to view this content.
Next post in General Oncology
